Education

• PhD in Nanomedicines, School of Pharmacy, University of Otago, New Zealand
• MSc. in Pharmaceutical Technology, School of Pharmaceutical Sciences, Universiti Sains Malaysia (USM), Malaysia
• B.Pharm. Faculty of Pharmacy, University of Karachi

Research Interests

• Nanoparticle-based formulation and advanced drug delivery.
• In vitro and in vivo evaluation of drug-loaded nanoparticles.
• Design and optimization of controlled released drug delivery system using polymers.
• Comparative analysis of brand-name drug to generic products.
• Development and validation of analytical methods using HPLC and LC-MS.
• Studies on the global burden of diseases.

Selected Publications

• Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990-2023: a Global Burden of Disease study. Nature Medicine. 2026; 32(1):197-223. doi: 10.1038/s41591-025-04077-9. 
• The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. 2025; 406(10512):1565-1586. doi: 10.1016/S0140-6736(25)01635-6. 
• Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023. Lancet. 2025;406(10513):1731-1810. doi: 10.1016/S0140-6736(25)01330-3. 
• Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. 2025; 406(10513):1811-1872. doi: 10.1016/S0140-6736(25)01917-8.
• The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990-2021: a cross-country systematic analysis with forecasts to 2050. Lancet Public Health. 2025;10 (11):e955-e970. doi: 10.1016/S2468-2667(25)00201-4. Epub 2025 Oct 10.
• Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023. J Am Coll Cardiol. 2025; 86(22):2167-2243. doi: 10.1016/j.jacc.2025.08.015. 
• Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study. Nature Medicine. 2025; 31(6):1809-1829. doi: 10.1038/s41591-025-03624-8.
  
• Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. 2025; 406(10513):1873-1922. doi: 10.1016/S0140-6736(25)01637-X. 
• Changing life expectancy in European countries 1990-2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021. Lancet Public Health. 2025;10(3):e172-e188. doi: 10.1016/S2468-2667(25)00009-X. 
  

Teaching Courses

• Pharmaceutics I
• Pharmaceutics II
• Pharmaceutics III
• Pharmacy Practice
• Industrial Training 
• Pharmaceutical Compounding

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all.

This person’s work contributes towards the following SDG(s):